Cargando…

Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas

Gastric adenocarcinomas represent frequent malignant tumors in the digestive tract, with a high and constant mortality rate in last decades. The disturbance of the adhesion molecules expression, which normally is essential in maintaining epithelial homeostasis, has a critical role in the initiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Creţu, Oana Iulia, Simionescu, Cristiana Eugenia, Florescu, Mirela Marinela, Stepan, Mioara Desdemona, Sapalidis, Konstantinos, Stepan, Alex Emilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926152/
https://www.ncbi.nlm.nih.gov/pubmed/36588491
http://dx.doi.org/10.47162/RJME.63.3.07
_version_ 1784888216060428288
author Creţu, Oana Iulia
Simionescu, Cristiana Eugenia
Florescu, Mirela Marinela
Stepan, Mioara Desdemona
Sapalidis, Konstantinos
Stepan, Alex Emilian
author_facet Creţu, Oana Iulia
Simionescu, Cristiana Eugenia
Florescu, Mirela Marinela
Stepan, Mioara Desdemona
Sapalidis, Konstantinos
Stepan, Alex Emilian
author_sort Creţu, Oana Iulia
collection PubMed
description Gastric adenocarcinomas represent frequent malignant tumors in the digestive tract, with a high and constant mortality rate in last decades. The disturbance of the adhesion molecules expression, which normally is essential in maintaining epithelial homeostasis, has a critical role in the initiation and progression of tumors. In this study, we analyzed the immunoexpression of E-cadherin, cluster of differentiation 44 (CD44), and Claudin 7 in 58 cases of gastric adenocarcinomas, in relation to the histopathological parameters of the lesions’ aggressiveness. Increased E-cadherin immunoexpression was observed in tubular adenocarcinomas, those of low grade and in stages I–III. CD44 presented high scores in discohesive, hepatoid, tubular, and tubulopapillary adenocarcinomas, those of high grade and in advanced stages. Claudin 7 associated increased scores for tubular, tubulopapillary and micropapillary tumors, those of low grade and mainly in stage I. The markers used in the study can be useful for assessing the aggressiveness of gastric adenocarcinomas, in the context of specific adapted therapy.
format Online
Article
Text
id pubmed-9926152
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
record_format MEDLINE/PubMed
spelling pubmed-99261522023-02-15 Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas Creţu, Oana Iulia Simionescu, Cristiana Eugenia Florescu, Mirela Marinela Stepan, Mioara Desdemona Sapalidis, Konstantinos Stepan, Alex Emilian Rom J Morphol Embryol Original Paper Gastric adenocarcinomas represent frequent malignant tumors in the digestive tract, with a high and constant mortality rate in last decades. The disturbance of the adhesion molecules expression, which normally is essential in maintaining epithelial homeostasis, has a critical role in the initiation and progression of tumors. In this study, we analyzed the immunoexpression of E-cadherin, cluster of differentiation 44 (CD44), and Claudin 7 in 58 cases of gastric adenocarcinomas, in relation to the histopathological parameters of the lesions’ aggressiveness. Increased E-cadherin immunoexpression was observed in tubular adenocarcinomas, those of low grade and in stages I–III. CD44 presented high scores in discohesive, hepatoid, tubular, and tubulopapillary adenocarcinomas, those of high grade and in advanced stages. Claudin 7 associated increased scores for tubular, tubulopapillary and micropapillary tumors, those of low grade and mainly in stage I. The markers used in the study can be useful for assessing the aggressiveness of gastric adenocarcinomas, in the context of specific adapted therapy. Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2022 2022-09-30 /pmc/articles/PMC9926152/ /pubmed/36588491 http://dx.doi.org/10.47162/RJME.63.3.07 Text en Copyright © 2022, Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
spellingShingle Original Paper
Creţu, Oana Iulia
Simionescu, Cristiana Eugenia
Florescu, Mirela Marinela
Stepan, Mioara Desdemona
Sapalidis, Konstantinos
Stepan, Alex Emilian
Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
title Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
title_full Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
title_fullStr Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
title_full_unstemmed Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
title_short Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
title_sort immunoexpression of e-cadherin, cd44 and claudin 7 in gastric adenocarcinomas
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926152/
https://www.ncbi.nlm.nih.gov/pubmed/36588491
http://dx.doi.org/10.47162/RJME.63.3.07
work_keys_str_mv AT cretuoanaiulia immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas
AT simionescucristianaeugenia immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas
AT florescumirelamarinela immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas
AT stepanmioaradesdemona immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas
AT sapalidiskonstantinos immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas
AT stepanalexemilian immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas